MetaCap

Moving iMage Technologies (MITQ) vs Niki BioSolutions (NIKI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Moving iMage Technologies is the larger company by market cap ($5.4 million vs $4.9 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MITQ-5.27%NIKI-66.24%
+8%-32%-71%
Oct 7, 20261 yearNov 20, 2026
MITQ-9.46%NIKI-60.75%
+3%-30%-64%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MITQ versus NIKI key metrics
MetricMITQNIKI
Share price$0.538$1.57
Market cap$5.35M$4.90M
1-day change-3.24%-6.55%
YTD return—-85.19%
1-year return—-87.92%
5-year return—-99.18%
EPS (TTM)$-0.03$-2.90
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$17.32M—
Revenue growth (YoY)-4.57%—
Net income (latest FY)$-297.00K$-1.36M
Gross margin29.06%—
Operating margin-2.88%—
Net margin-1.72%—
52-week high$0.81$14.40
52-week low$0.42$1.42
Distance from 52-week high-33.58%-89.10%
Average volume115.37K97.67K
Shares outstanding9.95M2.94M
Employees251
SectorConsumer DiscretionaryIndustrials
IndustryIndustrial Machinery/ComponentsIndustrial Machinery/Components

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • The two companies sit in different sectors: Moving iMage Technologies in Consumer Discretionary and Niki BioSolutions in Industrials.

About Moving iMage Technologies

MITQ stock →

Moving iMage Technologies, Inc. designs, manufactures, integrates, installs, and distributes proprietary and custom designed equipment, and other off the shelf cinema products for cinema requirements in the United States and internationally.

Consumer Discretionary · Industrial Machinery/Components · 25 employees

About Niki BioSolutions

NIKI stock →

Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in a Phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in a Phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa.

Industrials · Industrial Machinery/Components · 1 employees

MITQ vs NIKI FAQ

Which is bigger, Moving iMage Technologies or Niki BioSolutions?

Moving iMage Technologies (MITQ) is larger, with a market capitalization of $5.35M compared with $4.90M for Niki BioSolutions (NIKI).

Are Moving iMage Technologies and Niki BioSolutions in the same industry?

Yes. Both are classified in the Industrial Machinery/Components industry within the Consumer Discretionary sector.

More comparisons